Archit Organosys
- Market cap
- ₹ 119 Cr.
- P/E
- 334.9x
- P/B
- 1.66x
- 52-week range
- 34 – 71.99
- ROE
- 11%
- ROCE
- 13%
- Dividend yield
- 1.6%
- Debt / equity
- 0.33
- Sector
- Chemicals & Petrochemicals
- Industry
- Commodity Chemicals
- Listed on
- BSE
About
Archit Organosys Limited is an India-based company, which is engaged in the business of manufacturing and selling various chemical products. The Company operates through the Manufacturing and trading of Chemicals and Organics segment. The Company has two geographical segments, which include India and the Rest of the World. The Company is involved in manufacturing Monochloroacetic Acid (MCA) and Sodium Monochloroacetate (SMCA), which are used in the synthesis of various agricultural chemicals, cosmetic surfactants, oil drilling chemicals, plastic additives and others. The Company has developed various products, such as MCA, SMCA, Chloroacetyl Chloride (CAC), and Trichloroacetyl Chloride (TCAC). Its customers include several large Indian and international companies who are engaged in the agrochemical manufacturing sector, the pharmaceutical manufacturing sector and the cosmetics manufacturing sector.
Quick check
The five things to look at first. Open one for more.
Compared with its industry
Commodity Chemicals: 75 companies →Archit Organosys against the typical company in its industry. The rank is out of the companies that report each figure; green means the better quarter of the pack, red the worse quarter.
- Valuation (P/E)334.9 against a typical 22.7: pricier than most peers (1st = cheapest).69th of 72
- Sales growth+11.7% against a typical +12.7% from a year earlier.35th of 65
- Profit growth−28.9% against a typical +13.6% from a year earlier.35th of 49
- Share price, 3 months+12.2% against a typical −2.2%.13th of 65
- Size₹ 119.5 Cr. market value against a typical ₹ 131.2 Cr. (1st = largest).38th of 69
Financials
Consolidated figures in ₹ crore.
| ₹ Cr. | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 26 | 25 | 31 | 27 | 30 | 26 | 43 | 33 | 33 | 38 | 37 | 37 |
| Expenses | 24 | 24 | 31 | 24 | 27 | 23 | 39 | 29 | 30 | 34 | 32 | 34 |
| Operating Profit | 2 | 1 | 0 | 3 | 3 | 3 | 4 | 4 | 3 | 5 | 5 | 3 |
| OPM % | 8% | 4.4% | 0.9% | 11.3% | 9.7% | 10.3% | 10.2% | 12.5% | 8.2% | 12.2% | 13.4% | 9.1% |
| Other Income | 1 | 1 | 4 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | −0 | 1 |
| Interest | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 1 | 1 | 1 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 2 | 1 | 1 | 1 | 2 | 2 | 1 | 2 |
| Profit before tax | 1 | −1 | 2 | 1 | 1 | 2 | 3 | 3 | 2 | 4 | 2 | 2 |
| Tax % | 27.5% | −29.7% | 21.5% | 29.1% | 15% | 37.4% | 38.7% | 33.1% | 21.8% | 30.9% | 18.2% | 28.6% |
| Net Profit | 0 | −0 | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 |
| EPS in Rs | 0.18 | −0.22 | 0.87 | 0.49 | 0.5 | 0.49 | 0.98 | 0.99 | 0.75 | 1.18 | 0.98 | 0.71 |
Growth and returns
Compounded yearly rates over each period.
- 10 Years
- 11%
- 5 Years
- 8%
- 3 Years
- 3%
- TTM
- 10%
- 10 Years
- 19%
- 5 Years
- 9%
- 3 Years
- −6%
- TTM
- 22%
- 10 Years
- 16%
- 5 Years
- 10%
- 3 Years
- 8%
- TTM
- —
- 10 Years
- 7%
- 5 Years
- 10%
- 3 Years
- 7%
- TTM
- —
P/E and EPS over time
Daily P/E and trailing 12-month EPS. EPS updates with each result.
Peers
Listed companies in the same business.
| Archit Organosys | ₹ 65.03 | ₹ 119 Cr. | 334.9x | 1.7x | 11% | — |
| Asian Paints | ₹ 2,305.00 | ₹ 2,21,095 Cr. | 59.2x | 12.3x | — | 13% |
| Solar Industries India | ₹ 18,320.00 | ₹ 1,65,778 Cr. | 96.2x | 27x | 31.4% | 17.7% |
| Pidilite Industries | ₹ 1,514.00 | ₹ 1,54,107 Cr. | 70.4x | 16x | — | 17.4% |
| SRF | ₹ 2,309.00 | ₹ 68,444 Cr. | 40.1x | 5.5x | — | 12.7% |
| Berger Paints India | ₹ 465.00 | ₹ 54,219 Cr. | 56.4x | 9.4x | — | 9.9% |
Management
- Kandarp K. Amin
- Whole-Time Chairman of the Board
- Anilbhai Patel
- Chief Financial Officer
- Chirag Chouhan
- Compliance Officer, Company Secretary
- Archana K. Amin
- Whole-Time Director
- Archit Amin
- Whole Time Director
Prices are delayed and for information only. Nothing on this page is investment advice.